Process information
| Key Data Set Information | |
| Location | XC-AH-CN |
| Reference year | 2023 |
| Name |
|
| Technical purpose of product or process | It has inhibitory or bactericidal effect on gram-negative bacilli, such as Escherichia coli, Pseudomonas aeruginosa, Escherichia coli, Klebsiella pneumoniae, acidophilus, pertussis bacillus and dysentery bacillus. Clinically, it is mainly used for infections caused by sensitive bacteria, urinary tract infections caused by Pseudomonas aeruginosa, meningitis, sepsis, burn infections and mucocutaneous infections. |
| Classification |
Class name
:
Hierarchy level
|
| General comment on data set | It has inhibitory or bactericidal effect on gram-negative bacilli, such as Escherichia coli, Pseudomonas aeruginosa, Escherichia coli, Klebsiella pneumoniae, acidophilus, pertussis bacillus and dysentery bacillus. Clinically, it is mainly used for infections caused by sensitive bacteria, urinary tract infections caused by Pseudomonas aeruginosa, meningitis, sepsis, burn infections and mucocutaneous infections. |
| Copyright | No |
| Owner of data set | |
| Quantitative reference | |
| Reference flow(s) | |
| Time representativeness | |
| Time representativeness description | Environmental impact assessment report publication date |
| Technological representativeness | |
| Technology description including background system | Polymyxin B sulfate was produced by a pilot process, which included upstream culture, extraction and refinement |
| Flow diagram(s) or picture(s) | |
Modelling and validation
Administrative information
Inputs and Outputs